These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18688079)

  • 1. Ischemia-modified albumin level in type 2 diabetes mellitus - Preliminary report.
    Piwowar A; Knapik-Kordecka M; Warwas M
    Dis Markers; 2008; 24(6):311-7. PubMed ID: 18688079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of FPG, A1C and disease duration with protein markers of oxidative damage and antioxidative defense in type 2 diabetes and diabetic retinopathy.
    Reddy VS; Agrawal P; Sethi S; Gupta N; Garg R; Madaan H; Kumar V
    Eye (Lond); 2015 Dec; 29(12):1585-93. PubMed ID: 26381098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus.
    Kaefer M; Piva SJ; De Carvalho JA; Da Silva DB; Becker AM; Coelho AC; Duarte MM; Moresco RN
    Clin Biochem; 2010 Mar; 43(4-5):450-4. PubMed ID: 19968982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin.
    Ukinc K; Eminagaoglu S; Ersoz HO; Erem C; Karahan C; Hacihasanoglu AB; Kocak M
    Endocrine; 2009 Dec; 36(3):425-32. PubMed ID: 19784800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes mellitus without vascular complications and ischemia modified albumin.
    Dahiya K; Aggarwal K; Seth S; Singh V; Sharma TK
    Clin Lab; 2010; 56(5-6):187-90. PubMed ID: 20575465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde.
    Turk A; Nuhoglu I; Mentese A; Karahan SC; Erdol H; Erem C
    Retina; 2011 Mar; 31(3):602-8. PubMed ID: 21273947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Fluorescent Advanced Glycation End-Products and Vascular Complications in Type 2 Diabetic Patients.
    Guerin-Dubourg A; Cournot M; Planesse C; Debussche X; Meilhac O; Rondeau P; Bourdon E
    Biomed Res Int; 2017; 2017():7989180. PubMed ID: 29362717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High predictive ability of glycated hemoglobin on comparison with oxidative stress markers in assessment of chronic vascular complications in type 2 diabetes mellitus.
    D'Souza JM; D'Souza RP; Vijin VF; Shetty A; Arunachalam C; Pai VR; Shetty R; Faarisa A
    Scand J Clin Lab Invest; 2016; 76(1):51-7. PubMed ID: 26494020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.
    Ahmad Khan H
    Acta Diabetol; 2007 Dec; 44(4):193-200. PubMed ID: 17786383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood glucose fluctuation aggravates lower extremity vascular disease in type 2 diabetes.
    Jiao XM; Zhang XG; Xu XU; Yi C; Bin C; Cheng QP; Gong QQ; Lv XF
    Eur Rev Med Pharmacol Sci; 2014; 18(14):2025-30. PubMed ID: 25027342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes of the concentration of serum ischemia modified albumin and high sensitivity C-reactive protein in type 2 diabetic patients with retinopathy].
    Jia ZT; Liu CY; Li H
    Zhonghua Yan Ke Za Zhi; 2009 Sep; 45(9):805-8. PubMed ID: 20137285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIGNIFICANCE OF ISCHEMIA-MODIFIED ALBUMIN AS A SIMPLE MEASURE OF OXIDATIVE STRESS AND ITS DISCRIMINATORY ABILITY IN DIABETIC RETINOPATHY: Literature Review and Meta-Analysis.
    Seshadri Reddy V; Sethi S; Gupta N; Agrawal P; Chander Siwach R
    Retina; 2016 Jun; 36(6):1049-57. PubMed ID: 27105326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.
    Suguro T; Watanabe T; Kodate S; Xu G; Hirano T; Adachi M; Miyazaki A
    Clin Sci (Lond); 2008 Dec; 115(11):327-34. PubMed ID: 18338983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of glycated albumin as another glycemic control marker.
    Koga M; Kasayama S
    Endocr J; 2010; 57(9):751-62. PubMed ID: 20724796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic foot patients with and without retinopathy and plasma oxidative stress.
    Mohora M; Vîrgolici B; Coman A; Muscurel C; Găman L; Gruia V; Greabu M
    Rom J Intern Med; 2007; 45(1):51-7. PubMed ID: 17966443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia.
    Duarte MM; Rocha JB; Moresco RN; Duarte T; Da Cruz IB; Loro VL; Schetinger MR
    Clin Biochem; 2009 May; 42(7-8):666-71. PubMed ID: 19318029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.
    Artha IMJR; Bhargah A; Dharmawan NK; Pande UW; Triyana KA; Mahariski PA; Yuwono J; Bhargah V; Prabawa IPY; Manuaba IBAP; Rina IK
    Vasc Health Risk Manag; 2019; 15():149-157. PubMed ID: 31239693
    [No Abstract]   [Full Text] [Related]  

  • 20. Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia.
    Khan HA; Sobki SH; Khan SA
    Clin Exp Med; 2007 Mar; 7(1):24-9. PubMed ID: 17380302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.